CHG Jacques Lacarin (Vichy) Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2015
NCT02411331
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Centre Hospitalier Jacques Lacarin, Vichy | Jacques Lacarin Hospital Center

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 4